羧甲司坦可改善慢性阻塞性肺疾病患者的生活质量。 - Suppr

Suppr

超能文献

Carbocisteine improves quality of life in patients with chronic obstructive pulmonary disease.

作者信息

Tatsumi Koichiro, Fukuchi Yoshinosuke

出版信息

J Am Geriatr Soc. 2007 Nov;55(11):1884-6. doi: 10.1111/j.1532-5415.2007.01373.x.

DOI:10.1111/j.1532-5415.2007.01373.x

PMID:17979906

Abstract

摘要

相似文献

Carbocisteine improves quality of life in patients with chronic obstructive pulmonary disease.羧甲司坦可改善慢性阻塞性肺疾病患者的生活质量。

J Am Geriatr Soc. 2007 Nov;55(11):1884-6. doi: 10.1111/j.1532-5415.2007.01373.x.

Carbocisteine reduces frequency of common colds and exacerbations in patients with chronic obstructive pulmonary disease.

J Am Geriatr Soc. 2006 Feb;54(2):378-80. doi: 10.1111/j.1532-5415.2005.00592_9.x.

Pharmacological approaches to stable chronic obstructive pulmonary disease.

Br J Nurs. 2004;13(19):1130-4. doi: 10.12968/bjon.2004.13.19.16317.

Efficacy of carbocisteine in the treatment of chronic obstructive pulmonary disease and impact on the quality of life.羧甲司坦治疗慢性阻塞性肺疾病的疗效及对生活质量的影响。

Med Glas (Zenica). 2017 Aug 1;14(2):182-188. doi: 10.17392/906-17.

Tiotropium in chronic obstructive pulmonary disease.噻托溴铵用于慢性阻塞性肺疾病

N Engl J Med. 2009 Jan 8;360(2):185; author reply 187.

[Chronic obstructive pulmonary disease (COPD): diagnosis and treatment].[慢性阻塞性肺疾病（COPD）：诊断与治疗]

Dtsch Med Wochenschr. 2004 Mar 5;129(10):490-3. doi: 10.1055/s-2004-820537.

Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study.羧甲司坦对慢性阻塞性肺疾病急性加重的影响（PEACE研究）：一项随机安慰剂对照研究

Lancet. 2008 Jun 14;371(9629):2013-8. doi: 10.1016/S0140-6736(08)60869-7.

Carbocisteine for acute exacerbations of COPD.

Lancet. 2008 Nov 8;372(9650):1630-1; author reply 1631-2. doi: 10.1016/S0140-6736(08)61682-7.

[Long-acting bronchodilator agents are the choice in COPD. Keeping the airways open continuously].长效支气管扩张剂是慢性阻塞性肺疾病（COPD）的首选药物。持续保持气道通畅。

MMW Fortschr Med. 2007 Nov 22;149(47):54.

Carbocysteine therapy in older people with chronic obstructive pulmonary disease.羧甲司坦治疗老年慢性阻塞性肺疾病

J Am Geriatr Soc. 2006 Nov;54(11):1792-3; author reply 1793-4. doi: 10.1111/j.1532-5415.2006.00926.x.

引用本文的文献

Modular multi-enzyme cascades enable green and sustainable synthesis of non-canonical amino acids from glycerol.模块化多酶级联反应能够实现从甘油绿色可持续地合成非天然氨基酸。

Nat Commun. 2025 Aug 29;16(1):8079. doi: 10.1038/s41467-025-63341-1.

Anti-inflammatory effects of medications used for viral infection-induced respiratory diseases.用于治疗病毒感染引起的呼吸道疾病的药物的抗炎作用。

Respir Investig. 2023 Mar;61(2):270-283. doi: 10.1016/j.resinv.2022.11.002. Epub 2022 Dec 19.

Mucolytic and Antioxidant Properties of Carbocysteine as a Strategy in COVID-19 Therapy.羧甲司坦的黏液溶解和抗氧化特性作为COVID-19治疗策略

Life (Basel). 2022 Nov 8;12(11):1824. doi: 10.3390/life12111824.

Therapeutic Potential of Small Molecules Targeting Oxidative Stress in the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Comprehensive Review.靶向氧化应激的小分子治疗慢性阻塞性肺疾病（COPD）的治疗潜力：全面综述。

Molecules. 2022 Aug 28;27(17):5542. doi: 10.3390/molecules27175542.

Redox Dysregulation in Aging and COPD: Role of NOX Enzymes and Implications for Antioxidant Strategies.衰老与慢性阻塞性肺疾病中的氧化还原失调：NOX酶的作用及对抗氧化策略的影响

Antioxidants (Basel). 2021 Nov 11;10(11):1799. doi: 10.3390/antiox10111799.

Malnutrition, Airflow Limitation and Severe Emphysema are Risks for Exacerbation of Chronic Obstructive Pulmonary Disease in Japanese Subjects: A Retrospective Single-Center Study.营养不良、气流受限和严重肺气肿是日本 COPD 患者加重的危险因素：一项回顾性单中心研究。

Int J Chron Obstruct Pulmon Dis. 2020 Apr 22;15:857-868. doi: 10.2147/COPD.S238457. eCollection 2020.

Effects of a Long-Term Use of Carbocysteine on Frequency and Duration of Exacerbations in Patients with Bronchiectasis.长期使用羧甲司坦对支气管扩张症患者病情加重的频率和持续时间的影响

Open Access Maced J Med Sci. 2019 Dec 10;7(23):4030-4035. doi: 10.3889/oamjms.2019.697. eCollection 2019 Dec 15.

Carbocisteine inhibits the expression of Muc5b in COPD mouse model.羧甲司坦抑制慢性阻塞性肺疾病小鼠模型中黏蛋白5B的表达。

Drug Des Devel Ther. 2019 Sep 16;13:3259-3268. doi: 10.2147/DDDT.S198874. eCollection 2019.

Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine.黏液溶解/抗氧化剂在慢性阻塞性肺疾病中的疗效和安全性：厄多司坦、卡博司坦和乙酰半胱氨酸的比较分析。

Respir Res. 2019 May 27;20(1):104. doi: 10.1186/s12931-019-1078-y.

Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.黏液溶解剂与安慰剂治疗慢性支气管炎或慢性阻塞性肺疾病的比较

Cochrane Database Syst Rev. 2019 May 20;5(5):CD001287. doi: 10.1002/14651858.CD001287.pub6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验